Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 22
1946 105
1947 83
1948 102
1949 84
1950 131
1951 144
1952 153
1953 163
1954 161
1955 163
1956 159
1957 147
1958 120
1959 123
1960 141
1961 156
1962 166
1963 314
1964 401
1965 291
1966 311
1967 370
1968 502
1969 493
1970 453
1971 488
1972 443
1973 475
1974 479
1975 428
1976 406
1977 482
1978 491
1979 483
1980 514
1981 513
1982 589
1983 519
1984 538
1985 609
1986 638
1987 547
1988 521
1989 547
1990 542
1991 543
1992 578
1993 615
1994 592
1995 632
1996 599
1997 780
1998 697
1999 675
2000 741
2001 777
2002 716
2003 805
2004 844
2005 987
2006 1075
2007 1109
2008 1243
2009 1277
2010 1473
2011 1453
2012 1605
2013 1712
2014 1901
2015 2043
2016 2027
2017 2192
2018 2258
2019 1040
2020 9
Text availability
Article attribute
Article type
Publication date

Search Results

45,163 results
Results by year
Filters applied: . Clear all
Page 1
Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI.
Amiri H, et al. Neuroimage Clin 2018 - Review. PMID 29984155 Free PMC article.
As a consequence, it is challenging to investigate the role of GM atrophy in the disease process as well as the effect of treatments that aim to reduce neurodegeneration. In this paper we discuss the most important challenges currently hampering the measurement and interpretation of GM atrophy in MS. ...
As a consequence, it is challenging to investigate the role of GM atrophy in the disease process as well as the effect of treatments …
Pharmacotherapy for the treatment of vaginal atrophy.
Donders GGG, et al. Expert Opin Pharmacother 2019 - Review. PMID 30897020
INTRODUCTION: Despite its frequency, recognition and therapy of vulvovaginal atrophy (VVA) remain suboptimal. Wet mount microscopy, or vaginal pH as a proxy, allows VVA diagnosis in menopause, but also in young contraception users, after breast cancer, or postpartum. ...AREAS COVERED: The authors provide an overview of the current pharmaceutical treatment for vulvovaginal atrophy and provide their expert opinions on its future treatment. ...
INTRODUCTION: Despite its frequency, recognition and therapy of vulvovaginal atrophy (VVA) remain suboptimal. Wet mount microscopy, o …
The Effects of Meditation on Grey Matter Atrophy and Neurodegeneration: A Systematic Review.
Last N, et al. J Alzheimers Dis 2017 - Review. PMID 27983555
The present systematic review is based on the premise that a variety of neurodegenerative diseases are accompanied by grey matter atrophy in the brain and meditation may impact this. ...Limited research exists on the mechanisms through which meditation affects disease-related neurodegeneration, but preliminary evidence suggests that it may offset grey matter atrophy....
The present systematic review is based on the premise that a variety of neurodegenerative diseases are accompanied by grey matter atrophy
Testicular atrophy following inguinal hernia repair in children.
Sonderman KA, et al. Pediatr Surg Int 2018. PMID 29594470
PURPOSE: We sought to determine the incidence and timing of testicular atrophy following inguinal hernia repair in children. ...We excluded patients with history of testicular atrophy, malignancy or prior related operation. Our primary outcome was the incidence of the diagnosis of testicular atrophy. ...
PURPOSE: We sought to determine the incidence and timing of testicular atrophy following inguinal hernia repair in children. ...We ex …
Vulvar and Vaginal Atrophy: Physiology, Clinical Presentation, and Treatment Considerations.
Lev-Sagie A. Clin Obstet Gynecol 2015 - Review. PMID 26125962
Vulvovaginal atrophy is a common condition associated with decreased estrogenization of the vaginal tissue. Symptoms include vaginal dryness, irritation, itching, soreness, burning, dyspareunia, discharge, urinary frequency, and urgency. ...Despite the high prevalence and the substantial effect on quality of life, vulvovaginal atrophy often remains underreported and undertreated. ...
Vulvovaginal atrophy is a common condition associated with decreased estrogenization of the vaginal tissue. Symptoms include vaginal …
[Posterior cortical atrophy].
Solyga VM, et al. Tidsskr Nor Laegeforen 2015 - Review. PMID 26037756 Norwegian. Free article.
BACKGROUND: Posterior cortical atrophy is a neurodegenerative condition with atrophy of posterior parts of the cerebral cortex, including the visual cortex and parts of the parietal and temporal cortices. ...RESULTS: Posterior cortical atrophy causes gradually increasing impairment in reading, distance judgement, and the ability to perceive complex images. ...
BACKGROUND: Posterior cortical atrophy is a neurodegenerative condition with atrophy of posterior parts of the cerebral cortex …
Spinal Cord Atrophy in Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Casserly C, et al. J Neuroimaging 2018. PMID 30102003
BACKGROUND AND PURPOSE: Spinal cord atrophy (SCA) is an important emerging outcome measure in multiple sclerosis (MS); however, there is limited consensus on the magnitude and rate of atrophy. ...The pooled estimate of annual rate of SCA is greater than reported rates of brain atrophy in MS. These results demonstrate that SCA is highly relevant as an imaging outcome in MS clinical trials....
BACKGROUND AND PURPOSE: Spinal cord atrophy (SCA) is an important emerging outcome measure in multiple sclerosis (MS); however, there …
Post-menopausal vulvovaginal atrophy - an overview of the current treatment options.
Szymański JK, et al. Ginekol Pol 2018 - Review. PMID 29411346 Free article.
Vulvovaginal atrophy is a pathology resulting from those changes. VVA has a negative effect on the quality of life therefore prompting a search for new therapeutic options. The aim of this article is to summarize the current treatment modalities, both hormonal and non-hormonal for post-menopausal vaginal atrophy. ...
Vulvovaginal atrophy is a pathology resulting from those changes. VVA has a negative effect on the quality of life therefore promptin …
[Iridoschisis]
Meskini M, et al. J Fr Ophtalmol 2018. PMID 30442490 French.
45,163 results
Jump to page
Feedback